Letters to the Editor

• Olmesartan for the Prevention or Delay of Diabetic Nephropathy, Some Considerations

  Ferrán Catalá-López, Gloria Martín-Serrano, Miguel A. Maciá, Dolores Montero

  Rev Esp Cardiol. 2012;65:678-9

• Nutritional Status, Heart Failure and Minimum Basic Data Set. Response

  Antonio Zapatero, Raquel Barba, Javier Marco

  Rev Esp Cardiol. 2012;65:584

• P-Wave Terminal Force and Atrial Fibrillation, A Lesson Learned From Old Masters

  Maciej Wojcik, Malte Kuniss, Alexander Berkowitsch, Thomas Neumann

  Rev Esp Cardiol. 2012;65:584-5

• P-Wave Terminal Force and Atrial Fibrillation, A Lesson Learned From Old Masters. Response

  Javier Jiménez-Candil, Ana Martín-García, Cándido Martín-Luengo

  Rev Esp Cardiol. 2012;65:585-6

• Assessment of Renal Involvement by Cystatin C, A Forgotten Biomarker

  Alberto Domínguez-Rodriguez, Pedro Abreu-Gonzalez

  Rev Esp Cardiol. 2012;65:586-7

• Nutritional Status, Heart Failure and Minimum Basic Data Set

  Luis Angel Sánchez-Muñoz

  Rev Esp Cardiol. 2012;65:583

• Assessment of Renal Involvement by Cystatin C, A Forgotten Biomarker. Response

  Jose Luis Górriz Teruel, Sandra Beltrán Catalán

  Rev Esp Cardiol. 2012;65:587

• Change in Atrial Fibrillation Status, Comments to Val-FAAP Registry. Response

  Vivencio Barrios, Alberto Calderón, Carlos Escobar, Mariano de la Figuera

  Rev Esp Cardiol. 2012;65:491-2

• Change in Atrial Fibrillation Status, Comments to Val-FAAP Registry

  Rafael Vidal-Pérez, Fernando Otero-Raviña, Victorino Turrado Turrado, José Ramón González-Juanatey

  Rev Esp Cardiol. 2012;65:490-1

• Silent Embolism After Electrical Cardioversion of Atrial Fibrillation, What Does Brain Magnetic Resonance Imaging Provide? Response

  María Vázquez Caamaño

  Rev Esp Cardiol. 2012;65:490

• Silent Embolism After Electrical Cardioversion of Atrial Fibrillation, What Does Brain Magnetic Resonance Imaging Provide?

  Miguel A. Arias, Julio Casares-Medrano, Marta Pachón, Alberto Puchol

  Rev Esp Cardiol. 2012;65:489

• Comments on the Spanish Society of Cardiology Critical Review of the ESC 2010 Clinical Practice Guidelines on Atrial Fibrillation

  Gregory Y.H. Lip, A. John Camm

  Rev Esp Cardiol. 2012;65:390-1

• Ajmaline Test and ESC 2010 Clinical Practice Guidelines on Atrial Fibrillation. Response

  Manuel Anguita, Fernando Worner

  Rev Esp Cardiol. 2012;65:393

• Ajmaline Test and ESC 2010 Clinical Practice Guidelines on Atrial Fibrillation

  Moisés Rodríguez-Mañero, Andrea Sarkozy, Gian-Battista Chierchia, Pedro Brugada

  Rev Esp Cardiol. 2012;65:392-3

• Circulating Microparticles From Patients With Coronary Artery Disease Cause Endothelial Dysfunction

  Cristóbal Bueno Jiménez

  Rev Esp Cardiol. 2012;65:389

• Circulating Microparticles From Patients With Coronary Artery Disease Cause Endothelial Dysfunction. Response

  Jesus A. Araujo

  Rev Esp Cardiol. 2012;65:389-90

• Comments on the Spanish Society of Cardiology Critical Review of the ESC 2010 Clinical Practice Guidelines on Atrial Fibrillation. Response

  Manuel Anguita, Fernando Worner

  Rev Esp Cardiol. 2012;65:391-2

• Comment on the Article “Simultaneous Percutaneous Closure of Patent Foramen Ovale and Left Atrial Appendage”

  Rafael Hernández-Estefanía, Beltrán Levy-Praschker, Gregorio Rábago

  Rev Esp Cardiol. 2012;65:299

• Prognosis for Patients With Heart Failure With Preserved Ejection Fraction

  Javier Jacob, Pablo Herrero, Francisco Javier Martín Sánchez, Pere Llorens, Victor Gil, Oscar Miró

  Rev Esp Cardiol. 2012;65:300-1

• Comment on the Article “Simultaneous Percutaneous Closure of Patent Foramen Ovale and Left Atrial Appendage.” Response

  Manuel Paulo, Eulogio García, Rosa Ana Hernández-Antolín, Carlos Almería

  Rev Esp Cardiol. 2012;65:300